|
 |
Prostate Cancer > MAb
The following information is about MAb.
MAb Defined
MAXIMAL ANDROGEN BLOCKADE (see CHT)
This definition is in context to Prostate Cancer. See more contextual defintions for MAb.
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Published September 3, 2008, 9:24 am, Centre Daily Times
ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The application, submitted on August 29, 2008, was prepared in conjunction ...
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Published September 3, 2008, 9:00 am, Business Wire via Yahoo! Finance
NEW YORK----ImClone Systems Incorporated today announced that it has submitted an application to the U.S. Food and Drug Administration to broaden the use of ERBITUX® to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck .
ZymoGenetics and Merck Serono Restructure Partnership
Published September 3, 2008, 6:15 am, Centre Daily Times
ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced a restructuring of its partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. With respect to the ongoing development of atacicept, ZymoGenetics exercised its contractual right to convert to a worldwide royalty license. By making this election, ZymoGenetics will no longer be responsible for funding development costs, and ...
ZymoGenetics and Merck Serono Restructure Partnership
Published September 3, 2008, 3:00 am, Business Wire via Yahoo! Finance
SEATTLE----ZymoGenetics, Inc. today announced a restructuring of its partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. With respect to the ongoing development of atacicept, ZymoGenetics exercised its contractual right to convert to a worldwide royalty license.
Foundation gives $688,000 in grants
Published September 2, 2008, 9:28 pm, The Republican
SPRINGFIELD - The trustees of the Community Foundation of Western Massachusetts recently announced $688,600 in competitive grant awards to 64 local organizations.
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
Published September 1, 2008, 5:10 am, Medical News Today
ImClone Systems Incorporated (NASDAQ: IMCL) announced overall survival results from BMS CA225-099 (BMS-099), an open-label Phase 3 study of ERBITUX® (cetuximab) in combination with a taxane and carboplatin in the first-line treatment of all histological subtypes of advanced non-small cell lung cancer (NSCLC).
Monoclonal antibody sales to almost double by 2013
Published August 29, 2008, 6:39 pm, Pharmaceutical Business Review
In 2007, total global monoclonal antibody sales reached $26 billion and are forecast to almost double by 2013. Traditionally, the big five monoclonal antibodies have dominated the market, accounting for almost 80% of sales in 2007. However, Datamonitor has identified an emerging group of eight, each of which will achieve annual sales of at least $500 million between 2007-2013.
Are you looking for additional Prostate Cancer > Mab news? Try our new "Mab News Focus" area.
Off-site MAb Links, User Submitted
The following links have been collected through user bookmark submission in the MAb category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Fri Aug 29
Thu Aug 28
- Breadcrumbs for the mind: Mab's LiveJournal
- Bibliothekaris che Datenformate
Thu Aug 21
- Human IgG2 antibody disulfide rearrangement in vivo: ???????IgG2 ? hinge ? -SH ?? Light Chain ? -SH ??????
Tue Aug 19
Mon Aug 18
Thu Aug 14
- http://www.pal aisdetokyo.com /fo3/low/progr amme/index.php ?page=../media _clip/tokyocli ps.php: aspect vidéo présentation des exposants
- Designers in Residence: pour le design
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > MAb. If you would like to find related tags we recommend Tag Patterns > MAb
Off-site Mab Research Links
If you still need additional information on Mab then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Prostate Cancer Topics
Everything you need to know about Prostate Cancer
Prostate Cancer
If you know the Prostate Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Prostate-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.